Auld D. S., Mennicken F., Day J. C., Quirion R. (2001). Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons, J Neurochem, 77(1), 253-62.

Auld D. S., Mennicken F., Quirion R. (2001). Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences, J Neurosci, 21(10), 3375-82.

, Quirion R. (2001). The protective abilities of ginkgo biloba extract (EGb 761) against amyloid-induced toxicity depend on its flavonoid constituents . In Christen Y. (Ed.) , Advances Ginkgo Biloba Extracts Research (pp. 91-106). Solal.

, Quirion R. (2001). Resveratol and red wine constituents: Evaluation of their neuroprotectice properties, Pharm News, 8, 1-6.

Day J. C., Kornecook T. J., Quirion R. (2001). Application of in vivo microdialysis to the study of cholinergic systems, Methods, 23(1), 21-39.

Doré S., Quirion R. (2001). IGF-1, insulin, brain glucose, and cognition . In Craighead W. E. & Nemeroff C. B. (Eds.) , The Corsini Encyclopedia of Psychology and Behavioral Science (pp. 728-733). John Wiley & Sons, Inc..

Juaneda C., Dumont Y., Chabot J. G., Quirion R. (2001). Autoradiographic distribution of adrenomedullin receptors in the rat brain, Eur J Pharmacol, 421(2), R1-2.

Law A., Gauthier S., Quirion R. (2001). Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity, Br J Pharmacol, 133(7), 1114-24.

Law A., Gauthier S., Quirion R. (2001). Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type, Brain Res Brain Res Rev, 35(1), 73-96.

Ma W., Quirion R. (2001). Increased phosphorylation of cyclic AMP response element-binding protein (CREB) in the superficial dorsal horn neurons following partial sciatic nerve ligation, Pain, 93(3), 295-301.

Ma W., Zheng W. H., Belanger S., Kar S., Quirion R. (2001). Effects of amyloid peptides on cell viability and expression of neuropeptides in cultured rat dorsal root ganglion neurons: a role for free radicals and protein kinase C, Eur J Neurosci, 13(6), 1125-35.

Ma W., Zheng W. H., Powell K., Jhamandas K., Quirion R. (2001). Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study, Eur J Neurosci, 14(7), 1091-104.

Marcotte E. R., Srivastava L., Quirion R. (2001). DNA microarrays in neuropsychopharmacology, Trends Pharmacol Sci, 22(8), 426-36.

Mollereau C., Gouarderes C., Dumont Y., Kotani M., Detheux M., Doods H., Parmentier M., Quirion R., Zajac J. M. (2001). Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226, Br J Pharmacol, 133(1), 1-4.

Puma C., Danik M., Quirion R., Ramon F., Williams S. (2001). The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs, J Neurochem, 78(5), 960-71.

Redrobe J. P., Quirion R. (2001). Neuropeptide Y (NPY) as a potential target for the treatment of depressive illness: Y not?, Neurosci News, 4, 61-68.

Wood G. K., Marcotte E. R., Quirion R., Srivastava L. (2001). Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors, Eur J Neurosci, 14(6), 1030-4.